Neutrolis Inc.

Cambridge, MA

UEI
S2HJTYA3WC15
CAGE
80NY9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1 Broadway # 15, Cambridge, MA 02138, USA
Website
neutrolis.com
Founded
2017
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Targeting neutrophil extracellular traps for acute lung injury R43HL150944 National Heart Lung and Blood Institute (NIH) -$419,000
Genetic profiling of SLE patients with impaired net degradation. R43AI152955 National Institute of Allergy and Infectious Diseases (NIH) $251,744

Quick answers

Is Neutrolis Inc. registered in SAM.gov?

Yes. Neutrolis Inc.'s SAM.gov registration is active through March 31, 2027.

What is Neutrolis Inc.'s most recent federal award?

Neutrolis Inc.'s most recent federal grant award is Targeting neutrophil extracellular traps for acute lung injury (R43HL150944), from National Heart Lung and Blood Institute (NIH), on June 1, 2020.

On GovTribe

See Neutrolis Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login